BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 29778427)

  • 21. Application of the Subtractive Genomics and Molecular Docking Analysis for the Identification of Novel Putative Drug Targets against
    Hossain T; Kamruzzaman M; Choudhury TZ; Mahmood HN; Nabi AHMN; Hosen MI
    Biomed Res Int; 2017; 2017():3783714. PubMed ID: 28904956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Core Proteomic Analysis of Unique Metabolic Pathways of Salmonella enterica for the Identification of Potential Drug Targets.
    Uddin R; Sufian M
    PLoS One; 2016; 11(1):e0146796. PubMed ID: 26799565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In-silico Subtractive Proteomic Analysis Approach for Therapeutic Targets in MDR Salmonella enterica subsp. enterica serovar Typhi str. CT18.
    Rahman N; Muhammad I; Nayab GE; Khan H; Filosa R; Xiao J; Hassan STS
    Curr Top Med Chem; 2019; 19(29):2708-2717. PubMed ID: 31702501
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative genomics study of Salmonella Typhimurium LT2 for the identification of putative therapeutic candidates.
    Samal HB; Prava J; Suar M; Mahapatra RK
    J Theor Biol; 2015 Mar; 369():67-79. PubMed ID: 25637765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative genomic analysis and characterization of incompatibility group FIB plasmid encoded virulence factors of Salmonella enterica isolated from food sources.
    Khajanchi BK; Hasan NA; Choi SY; Han J; Zhao S; Colwell RR; Cerniglia CE; Foley SL
    BMC Genomics; 2017 Aug; 18(1):570. PubMed ID: 28768482
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genomics driven approach for identification of novel therapeutic targets in Salmonella enterica.
    Gawade P; Ghosh P
    Gene; 2018 Aug; 668():211-220. PubMed ID: 29778427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Salmonella pathogenicity islands in host specificity, host pathogen-interactions and antibiotics resistance of Salmonella enterica.
    Gerlach RG; Hensel M
    Berl Munch Tierarztl Wochenschr; 2007; 120(7-8):317-27. PubMed ID: 17715824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional Divergence of the Paralog
    Oke MT; D'Costa VM
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673776
    [No Abstract]   [Full Text] [Related]  

  • 29. Cellular microbiology of intracellular Salmonella enterica: functions of the type III secretion system encoded by Salmonella pathogenicity island 2.
    Kuhle V; Hensel M
    Cell Mol Life Sci; 2004 Nov; 61(22):2812-26. PubMed ID: 15558211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methods to Illuminate the Role of
    Young AM; Palmer AE
    Front Cell Infect Microbiol; 2017; 7():363. PubMed ID: 28848721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of two-component regulatory systems in environmental sensing and virulence in
    de Pina LC; da Silva FSH; Galvão TC; Pauer H; Ferreira RBR; Antunes LCM
    Crit Rev Microbiol; 2021 Aug; 47(4):397-434. PubMed ID: 33751923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emergence of Salmonella epidemics: the problems related to Salmonella enterica serotype Enteritidis and multiple antibiotic resistance in other major serotypes.
    Velge P; Cloeckaert A; Barrow P
    Vet Res; 2005; 36(3):267-88. PubMed ID: 15845226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Salmonella-how a metabolic generalist adopts an intracellular lifestyle during infection.
    Dandekar T; Fieselmann A; Fischer E; Popp J; Hensel M; Noster J
    Front Cell Infect Microbiol; 2014; 4():191. PubMed ID: 25688337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Phenotypic and molecular characteristics of Salmonella enterica serotype 1,4, [5] ,12:i:--a review].
    Yang X; Wu Q; Zhang J; Guo W
    Wei Sheng Wu Xue Bao; 2014 Nov; 54(11):1248-55. PubMed ID: 25752131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Salmonella enterica as a vaccine carrier.
    Hegazy WA; Hensel M
    Future Microbiol; 2012 Jan; 7(1):111-27. PubMed ID: 22191450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current knowledge and perspectives of potential impacts of Salmonella enterica on the profile of the gut microbiota.
    Aljahdali NH; Sanad YM; Han J; Foley SL
    BMC Microbiol; 2020 Nov; 20(1):353. PubMed ID: 33203384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rational identification of new antibacterial drug targets that are essential for viability using a genomics-based approach.
    Chalker AF; Lunsford RD
    Pharmacol Ther; 2002 Jul; 95(1):1-20. PubMed ID: 12163125
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.